Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05763407 · ClinicalTrials.gov registry record · NA
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
A NA study of Heart Failure, sponsored by Foundry Innovation & Research 1, Limited (FIRE1).
- Recruiting
- Registry status
- NA
- Development phase
- 25
- Enrollment target
- 8
- Study locations
NCT05763407 is a NA study of Heart Failure that is actively recruiting participants, run by Foundry Innovation & Research 1, Limited (FIRE1). The registered enrollment target is 25 participants, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (99% lower). The trial reports 8 study locations across 6 states.
The verdict
NCT05763407, a NA study of Heart Failure, is actively recruiting participants, sponsored by Foundry Innovation & Research 1, Limited (FIRE1).
- RECRUITING
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
- 8
- Study locations
Study Summary
Early Feasibility Study of the NORM™ System in Heart Failure Patients
Conditions Studied
Interventions
- DEVICE NORM™ System
Study Locations (8)
New York
- Columbia University Irving Medical Center/ New York Presbyterian Hospital - New York
- Rochester General Hospital - Rochester
Ohio
- Cleveland Clinic - Cleveland
- The Ohio State University Wexner Medical Center - Columbus
Minnesota
- University of Minnesota Medica Center - Minneapolis
North Carolina
- Duke University Medical Center - Durham
South Carolina
- Prisma Health - Greenville
Texas
- Austin Heart Central at the Heart Hospital of Austin - Austin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2023-06-19 |
| Est. Completion | 2027-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05763407
The ClinicalTrials.gov registry entry for NCT05763407 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (99% lower). The listed sponsor is Foundry Innovation & Research 1, Limited (FIRE1), which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which NORM™ System is the first listed.
NCT05763407 reports 8 study locations spanning 6 distinct geographic areas - top geographies include New York, Ohio, Minnesota.
Frequently Asked Questions
What is clinical trial NCT05763407 about?
NCT05763407 is a clinical study titled "Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)". Early Feasibility Study of the NORM™ System in Heart Failure Patients
What is the current status of trial NCT05763407?
This trial is currently recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2023-06-19. Estimated completion is 2027-12.
What conditions does trial NCT05763407 study?
This clinical trial studies the following conditions: Heart Failure.
What interventions are being tested in trial NCT05763407?
The interventions under investigation include: NORM™ System (DEVICE).
Who is sponsoring clinical trial NCT05763407?
This trial is sponsored by Foundry Innovation & Research 1, Limited (FIRE1), which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05763407 being conducted?
This trial has 8 study locations across Minnesota, New York, North Carolina, Ohio, South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
Optimizing Heart Failure Therapies Among Patients With Limited Access in Denver
RECRUITING · NA
-
Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial
RECRUITING · NA
-
Effect of a Quality Improvement Initiative to Address Social Determinants of Health on Rehospitalization Rates in Patients With Heart Failure
RECRUITING · NA
-
Mind Your Heart-II
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.